SSRI'S and other antidepressant use during pregnancy and potential neonatal adverse effects: Impact of a public health advisory and subsequent reports in the news media
<p>Abstract</p> <p>Background</p> <p>On Aug 9<sup>th </sup>2004 Health Canada released an advisory, which followed a similar one from the FDA regarding the use of SSRI's and other antidepressants during pregnancy and potential adverse effects on newborn...
Saved in:
Main Authors: | Halil R (Author), Schachtschneider AK (Author), Einarson A (Author), Bollano E (Author), Koren G (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2005-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Effects of CYP2C19 Genotype on Proxies of SSRI Antidepressant Response in the UK Biobank
by: Win Lee Edwin Wong, et al.
Published: (2023) -
Evaluation of the effect of long-term use of antidepressants in the SSRI group on bone density with dental volumetric tomography
by: Agacayak KS, et al.
Published: (2019) -
Post-SSRI sexual dysfunction and SSRI induced sexual dysfunction - literature review
by: Eliasz Panek, et al.
Published: (2023) -
The lived experience of withdrawal from Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants: A qualitative interview study
by: Raqeeb Mahmood, et al.
Published: (2024) -
Study of antinociceptive activity of SSRI (fluoxetine and escitalopram) and atypical antidepressants (venlafaxine and mirtazepine) and their interaction with morphine and naloxone in mice
by: Pranav Sikka, et al.
Published: (2011)